stockrowNexalin Technology, Inc.
NXLNexalin Technology, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $301,600.00, up 78.8% from fiscal 2024.
- Revenue
- −82.7%
- EPS
- −10.0%
- Free cash flow
- −97.2%
Quarter to June 2026, against a year earlier
Follow NXL
Alert me
Nexalin Technology, Inc. (NXL) Return on invested capital
Nexalin Technology, Inc.'s return on invested capital over the twelve months to 30 June 2026 was −1,108.8%, up 20037.6 percentage points from fiscal 2025 (−21,146.4%). Over the past ten years it has ranged from −21,146.4% (fiscal 2025) to 0.00% (fiscal 2022) — the current reading is the lowest in ten years. That is below the Medical Devices industry median of −5.22% and below the Healthcare sector median of 0.00%.
Return on invested capital, annual
Embed this chart
Annual newest first
| Period | Return on invested capital | Change (points) |
|---|---|---|
| FY2025 | −21,146.4% | (18,674.91) |
| FY2024 | −2,471.5% | (1,092.66) |
| FY2023 | −1,378.9% | (1,378.85) |
| FY2022 | 0.00% | 0.00 |
| FY2021 | 0.00% | 0.00 |
| FY2020 | 0.00% | 0.00 |
| FY2019 | 0.00% | — |
Against its own ten years
Return on invested capital against peers
| Company | Return on invested capital |
|---|---|
| GCTK GlucoTrack, Inc. compare | 0.00% |
| BJDX Bluejay Diagnostics, Inc. compare | 0.00% |
| DHAI DIH Holding US, Inc. compare | 0.00% |
| ICCM IceCure Medical Ltd. compare | 0.00% |
| NUVOQ Holdco Nuvo Group D.G Ltd. compare | 0.00% |
| IVF INVO Fertility, Inc compare | −27.9% |
| ADGM Adagio Medical Holdings, Inc. compare | −74.6% |
| CODX Co-Diagnostics, Inc. compare | −337.7% |
| NXL Nexalin Technology, Inc. | −1,108.8% |
| Medical Devices industry median | −5.22% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Return on invested capital is
Return on Invested Capital shows how much after-tax operating profit a company earns on the money its lenders and shareholders have put in.
TTM: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) (latest quarter) + Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter) − Cash & Short Term Investments (latest quarter)); Annual: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) + Long Term Debt (Total) + Current Part of Debt − Cash & Short Term Investments)